Advertisement

Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations

Open AccessPublished:June 23, 2022DOI:https://doi.org/10.1016/j.xkme.2022.100502
      To the Editor:
      We read with interest the recent article in which Fernandes et al
      • Fernandes G.
      • Devresse A.
      • Scohy A.
      • et al.
      Monoclonal antibody therapy in kidney transplant recipients with delta and omicron variants of SARS-CoV-2: a single-center case series.
      found that neutralizing monoclonal antibody therapy was associated with favorable outcomes among kidney transplant recipients presenting with mild COVID-19. We agree that neutralizing monoclonal antibody treatment may be beneficial. However, we highlight that additional information on patients’ immunologic state would be useful, including recent receipt of other transplant immunosuppression and underlying health conditions that may impact the susceptibility to developing severe COVID-19. Additionally, we wondered if any of these individuals had experienced past SARS-CoV-2 infection. In combination with vaccination, prior infection may reduce the risk of severe COVID-19.
      • Joob B.
      • Wiwanitkit V.
      Letter to the editor: coronavirus disease 2019 (COVID-19), infectivity, and the incubation period.

      Article Information

      Financial Disclosure

      The authors declare that they have no relevant financial interests.

      Peer Review

      Received May 2, 2022. Direct editorial input from the Editor-in-Chief. Accepted in revised form May 11, 2022.

      References

        • Fernandes G.
        • Devresse A.
        • Scohy A.
        • et al.
        Monoclonal antibody therapy in kidney transplant recipients with delta and omicron variants of SARS-CoV-2: a single-center case series.
        Kidney Med. 2022; 4100470
        • Joob B.
        • Wiwanitkit V.
        Letter to the editor: coronavirus disease 2019 (COVID-19), infectivity, and the incubation period.
        J Prev Med Public Health. 2020; 53: 70

      Linked Article